---
type: validation
section: 2
pass: "2-reverify"
status: PASS
date: "2026-07-25"
built_by: qa-review-agent
target: vault/Projects/Business_Plan_Drafts_v2/Section_02_Business_Description.md
---

# QA Re-verification — Section 2 (v2), post-Pass 2 fix cycle

**Verdict: PASS.** All three blocking findings from `QA_Review_Section_02_v2_pass2.md` (FAIL,
2026-07-24) are genuinely resolved — not softened or worked around. Spot-checks of every edited
passage found no new blocking defect. All three gates re-confirmed PASS on the edited text.
Section 2 has earned **Done (independently verified)**. Per this task's scope, the tracker was
**not** modified — the status flip is reported here for the Orchestrator to apply.

Independence statement: this re-verification was performed in a fresh thread that neither drafted
nor fixed the section. Every load-bearing claim in the fixes was re-traced to the primary artifacts
on disk (`DEC-009`, `Assumptions_Register.md`, the five `OPT-` files' frontmatter,
`Topics/2026 Investment Programme.md`, `Scenarios_v2.md`, `Citation_Audit_Section_02_v2_pass2.md`),
not taken from the fix record's own assertions.

---

## Blocking findings — resolution status

### B1 (ASM-015–028 status misstated) — RESOLVED

§2.4 now reads: assumptions "tagged, confidence-rated, registered `Proposed`, and individually
reviewed to `Approved` status (2026-07-23) before any number is cited as settled." Verified against
`vault/Decisions/Assumptions_Register.md` directly: all of ASM-015–033 carry `Status: Approved`,
and the register's own footnote confirms "All fourteen rows moved `Proposed` → `Approved`
2026-07-23." The fix uses exactly the restatement B1 prescribed (Proposed-then-Approved with the
date), so it is neither a softening nor a workaround. (ASM-021's `Last updated: 2026-07-24` is a
"Used in" refresh, not a status change — the 2026-07-23 approval date the draft states remains
correct.)

### B2 (DEC-009 treated as open; sequence never stated) — RESOLVED

Verified against `DEC-009` (frontmatter `status: approved`, `resolved_date: 2026-07-23`, resolution
"middle path"; Decision §1: "OPT-002 and OPT-003 as the near-term, low-risk/high-fit priority;
OPT-001 and OPT-005 continue-at-pace; OPT-004 as the longer-horizon build"). The body now commits
to exactly that sequence, in the body prose and not merely a header addendum, in four places:
the Answer block, §2.2 problem 2, §2.3, and §2.6. The option descriptors match DEC-009's own
scoping (OPT-002 talabat pro Egypt/Iraq; OPT-003 Food-leadership CVP/partner-retention GCC-3;
OPT-001 dark-store densification; OPT-005 AI/personalisation scaling; OPT-004 advertising
monetization). DEC-009's mandatory disclosure rule is respected: no ASM-029–033 dollar range
appears anywhere in the section, and §2.3 correctly states the ranges are confined to labeled
sensitivity/appendix exhibits. The provenance note's neutral framing is date-stamped historical
with an explicit forward pointer to the 2026-07-24 addendum. The draft correctly presents the
sequence as the committed recommendation ("This plan commits to that sequence narratively"), not a
neutral ranking. Full resolution, faithful to the decision as recorded.

### B3 (no independent citation re-check; inaccurate closure claim) — RESOLVED

`Citation_Audit_Section_02_v2_pass2.md` is on file: independent (trace formed before reading
Pass 1), built by `evidence-citation-agent`, dated 2026-07-24, **PASS with 0 hard failures** —
this supplies the independent re-check B3 required. The specific defect B3 identified is fixed:
§2.6 now carries the inline TLB-025 citation ("IPO priced November 2024, TLB-025"). The
frontmatter status line accurately describes the true verification state rather than overstating it.

**Sequencing note (accepted, with reasoning):** the Pass 2 citation audit was run on the *pre-fix*
text (its soft findings S-1–S-5 quote pre-fix wording). The post-fix edits were not re-audited by a
Pass 3 citation thread. This is acceptable because every claim the edits introduced either (a)
resolves to material the Pass 2 audit itself verified (TLB-025 pricing date, row 6; the ~4.6%
mid-range and 4.4–4.8% guidance band, row 11; the 11-criterion comparison and DEC-009 approval,
rows 12–13; ASM statuses, row 18; OPT `candidate` statuses, row 22; the GMV/adjacent-pillars
recomposition, row 24 — the fix implements the audit's own prescribed wording), or (b) was
independently re-traced in this re-verification (DEC-009 sequence and disclosure rule; register
statuses; OPT frontmatter; `Topics/2026 Investment Programme.md` lines 10–12; `Scenarios_v2.md`
guidance anchor). No new untraceable claim exists.

---

## Spot-check of edited passages — new defects

No new blocking defects. Three non-blocking observations (recorded for a future pass; none affects
the verdict):

- **R1 — band-citation precision (§2.3, traceability row 4).** "the guided mid-range of the
  4.4–4.8% band" is cited inline to "TLB-014, pages 6 and 19; `Topics/2026 Investment
  Programme.md`". The cited topic note carries the 6.0%→~4.6% endpoints and the "mid-range"
  framing (TLB-014 p.6, p.19), but the explicit 4.4–4.8% band figure lives in `Scenarios_v2.md`'s
  guidance anchor, cited there to TLB-019 p.18, TLB-020 p.14, TLB-014 p.9. The figure is disclosed
  guidance, fully traceable, and arithmetically consistent (mid-point of 4.4–4.8 = 4.6) — but the
  band's page attribution would be more precise citing TLB-014 p.9 (or `Scenarios_v2.md`'s anchor)
  alongside. Same class as the closed S-2; non-blocking.
- **R2 — residual header inconsistency.** The provenance note still contains the drafting-time
  sentence "This is a **Pass 1, self-reviewed draft** — a genuinely independent citation audit and
  QA review... are still required," which is now historically outdated (both independent passes
  have since run, as the frontmatter and 2026-07-24 addendum state). The neutral-framing sentence
  got a historical date-stamp in the fix cycle; this sentence did not. Cosmetic — the addendum two
  paragraphs later corrects the record — but a future pass should date-stamp it the same way.
- **R3 — inherited items remain owed upstream, correctly not closed here:** the `Topics/AI.md`
  Group-wide refresh (N1, with `research-agent`), the `Value_Driver_Tree_v2.md` node-arithmetic
  footnote (N4/S-6, with forecasting-agent/decision-steward), and the `Problem_Charter.md`
  "December 2024" IPO-date discrepancy (S-5, with `decision-steward`). All are correctly flagged in
  the draft or forwarded, and none is a Section 2 defect.

Non-blocking fixes N2 (bridge "~"/mid-range restored), N3 (MECE orthogonality softening — the new
closing paragraph correctly claims orthogonality of dimensions, not decisions), and the audit's
S-3/S-4/S-5 (marketplace inline cite; GMV attached to transacting verticals only, with the
TLB-001 p.27 subscription-exclusion cite; "priced November 2024") were all verified as applied
correctly with no new distortion introduced.

---

## Gate re-confirmation on the edited text

- **Problem Consistency Gate — PASS (8/8 re-confirmed).** The edits change no problem framing,
  scope, or envelope claim: USD175mn = ~120 + ~55 throughout; the sequence commitment answers the
  charter's decision question rather than altering it; no "MENA" introduced (the term still appears
  only inside the verbatim TLB-020 p.16 quote); no pre-pivot residue introduced.
- **Financial Integrity Gate (DEC-010/DEC-008) — PASS (11/11 re-confirmed).** New figures
  introduced by the edits (4.4–4.8% band; ~4.6% restored as "~" mid-range) are disclosed guidance,
  internally consistent, correctly unit-labeled (% of GMV), and cure the check-10 false-precision
  note. DEC-008 remains respected: no 2.2:1 exhibit, headline financials still deferred to
  Section 9 at Group base-case level. DEC-009's disclosure rule adds a further constraint the
  section also meets: no ASM-029–033 dollar figure appears.
- **Geographic Evidence Gate — PASS (9/9 re-confirmed).** The only new geography content is the
  option-scoped tags (OPT-002 Egypt/Iraq; OPT-003 GCC-3), which match those options' own evidence
  scoping in DEC-009 exactly — no metric transfer, no untagged inference, no Group figure presented
  as country-proven. The GMV recomposition keeps the figure Group-level and attached to the
  transacting verticals only.

---

## Disposition

**PASS.** Section 2 (v2) meets the standard for **✅ Done (independently verified)**: template
completeness and McKinsey Lens (passed at Pass 2, untouched by the edits except the N3
improvement), independent citation audit PASS on file, B1–B3 resolved and independently
re-verified, and all three gates PASS on the edited text. Per task scope this reviewer did **not**
edit the draft or the tracker — the Orchestrator should flip the tracker status cell and may carry
R1/R2 (cosmetic) and R3 (upstream) into the normal backlog without blocking.
